Search Count: 352
 |
Cryo Em Structure Of Sars-Cov-2 (Ba.4) Rbd In Complex With Thz937 Fab (Local Refine)
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus
Method: ELECTRON MICROSCOPY Release Date: 2026-09-16 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus
Method: ELECTRON MICROSCOPY
Release Date: 2026-09-16
Ligands: NAG
 |
Complex Structure Of Thz-65 Fab Bound To Sars-Cov-1 Rbd
Organism: Homo sapiens, Severe acute respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.78 Å Release Date: 2026-09-16 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
Organism: Homo sapiens, Severe acute respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2026-09-16
 |
Complex Structure Of Thz-939 Fab Bound To Sars-Cov-2 Wt Rbd
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:3.54 Å Release Date: 2026-09-16 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-09-16
 |
Cd38 In Complex With 028 Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.15 Å Release Date: 2026-05-27 Classification: MEMBRANE PROTEIN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-27
 |
Gpr151-Legobody Complex
Organism: Escherichia coli o157:h7, Staphylococcus aureus, Staphylococcus aureus subsp. aureus mu50, Streptococcus sp. 'group g', Homo sapiens, Spodoptera frugiperda
Method: ELECTRON MICROSCOPY Resolution:3.08 Å Release Date: 2026-05-06 Classification: MEMBRANE PROTEIN |
 |
Cryo-Em Structure Of Gpr151-Nb6 Complex
Organism: Homo sapiens, Spodoptera frugiperda
Method: ELECTRON MICROSCOPY Resolution:2.76 Å Release Date: 2026-05-06 Classification: MEMBRANE PROTEIN |
Organism: Homo sapiens, Spodoptera frugiperda
Method: ELECTRON MICROSCOPY
Release Date: 2026-05-06
 |
Sars-Cov-2 Nsp14 With 1-(4-Methylphenyl)-2-(2-Methylsulfanyl-4,5-Dihydroimidazol-1-Yl)Ethanone
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9H, DMS, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9H, DMS, ZN
 |
Sars-Cov-2 Nsp14 With 2,5-Dichlorothiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1AYN, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1AYN, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With Ethyl 2-(1H-Indol-3-Yl)Acetate
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9J, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9J, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2,5-Dimethylpyrazol-3-Amine
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9K, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9K, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With N-Methyl-1-(2-Methyl-5-Phenylpyrazol-3-Yl)Methanamine
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: X6W, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: X6W, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 1-Benzofuran-3-Carboxylic Acid
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JA8, DMS, EPE, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JA8, DMS, EPE, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2-(1H-Indol-3-Yl)Ethanol
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: ZCW, DMS, PO4, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: ZCW, DMS, PO4, ZN
 |
Sars-Cov-2 Nsp14 With Benzenesulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: FB2, EPE, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: FB2, EPE, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 5-Chlorothiophene-2-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: GOL, 8K2, EPE, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: GOL, 8K2, EPE, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 3,4-Dichlorobenzenesulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBC, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBC, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2,5-Dichloro-4-Methylthiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBA, DMS, EPE, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBA, DMS, EPE, ZN, PO4
 |
Sars-Cov-2 Nsp14 With 2,5-Dichlorothiophene-3-Sulfonic Acid
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JA9, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JA9, DMS, ZN, PO4
 |
Sars-Cov-2 Nsp14 With Thiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBB, DMS, EPE, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBB, DMS, EPE, ZN
 |
Sars-Cov-2 Nsp14 With 6-Methyl-2-[(4-Methylphenyl)Methyl]Pyridazin-3-One
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2026-04-15 Classification: VIRAL PROTEIN Ligands: A1I9I, DMS, PO4, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-15
Ligands: A1I9I, DMS, PO4, ZN